Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.
about
Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population.Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trialParaoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCIAchieving secondary prevention low-density lipoprotein particle concentration goals using lipoprotein cholesterol-based dataImpact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?Cardiovascular risk in Gullah African Americans with high familial risk of type 2 diabetes mellitus: project SuGAR.The genetic architecture of lipoprotein subclasses in Gullah-speaking African American families enriched for type 2 diabetes: the Sea Islands Genetic African American Registry (Project SuGAR).A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes.Hepatic lipase as a focal point for the development and treatment of coronary artery disease.Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome.Cholesteryl ester transfer protein gene polymorphisms and longevity syndromeA genomewide search using an original pairwise sampling approach for large genealogies identifies a new locus for total and low-density lipoprotein cholesterol in two genetically differentiated isolates of Sardinia.Lipoproteins: When size really matters.Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet - the RESOLVE trial.Fluvastatin: effects beyond cholesterol lowering.Perspectives on vascular biology and diabetes.Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B)Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials.Assessing the role of oestrogen in the prevention of cardiovascular disease.Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twinsEffects of diet on genetic regulation of lipoprotein metabolism in baboons.Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiencyLow HDL cholesterol is associated with increased atherogenic lipoproteins and insulin resistance in women classified with metabolic syndrome.Guinea pigs: a suitable animal model to study lipoprotein metabolism, atherosclerosis and inflammation.Management of cardiovascular risk factors with pioglitazone combination therapies in type 2 diabetes: an observational cohort study.Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.A higher burden of small low-density lipoprotein particles is associated with profound changes in the free androgen index in male adolescents.Combination drug treatment in obese diabetic patientsAtheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy.LDL cholesterol estimation in patients with the metabolic syndrome.Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentChanges in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.Energy substrate partitioning and efficiency in individuals with atherogenic lipoprotein phenotypePolycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weightCholesteryl ester transfer protein, low density lipoprotein particle size and intima media thickness in patients with coronary heart disease.Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease.Rosiglitazone increases small dense low-density lipoprotein concentration and decreases high-density lipoprotein particle size in HIV-infected patientsSmaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients.Rosiglitazone and fenofibrate additive effects on lipidsImplications of plasma concentrations of adiponectin in patients with coronary artery disease.
P2860
Q25255948-175D3136-B66E-482B-B2AE-D84986648DE6Q28351795-5292575C-C64A-4F0A-A6BA-B0CF5A2C4328Q28486151-48612865-57AA-461F-BB45-75E8A6DEF683Q28730849-08137680-D726-429A-82ED-A2A1B4B2EA59Q30234825-99DE8D8C-8F10-4522-BA43-AE141A4122DEQ30303166-A57CFEF0-4472-4A06-AB58-96224FA6847EQ30433072-953E3577-A5BA-4704-950F-A1E7C5F291A1Q30789864-2AB68E23-9799-4A2F-B769-74271AADDCD6Q32056551-1742E6E8-6BBB-49B1-8614-109A408A2668Q33675642-E4B47C35-C392-4639-8C82-3A854F322B7FQ33699478-8A524104-98A6-41CC-B6A0-533C376AF70EQ33910521-9B884318-387C-4012-BE08-432DE0FB25F1Q33947533-8B2C4218-C466-44E6-B83E-89F534DA8E91Q33970276-614F8FA4-AA4B-445B-A20D-51CDD0DC5BD9Q34126048-34CBDBF1-BDA2-46C9-A379-B4145E572DDAQ34161037-684EE933-D94F-4001-A8FB-C30A820233B0Q34297063-5A686631-2B1C-43C4-82C1-2E8FC8A17A9EQ34303796-F4376814-4D51-4483-BE8E-681763608B85Q34329552-19DA213D-8382-4377-96E2-8AB02A131CEEQ34384470-411C5780-3936-40E5-94B9-818DA79C5B82Q34384646-1EE0EB13-8AC6-4667-BAB2-CCCA54F54E84Q34388982-1ADF8A5F-DB09-4751-B44D-4584742EFC3BQ34534397-557DAE30-764F-452E-8304-664A8BBDD7AAQ34538168-4FE917DA-D93A-4C77-9FB8-08882356D5A7Q34592900-9DFC9A31-606B-4DCB-84FA-2E91B0F4D81AQ34692452-67986832-4D96-4E8A-80E0-32E3771DFE0CQ34753393-5CB37D5D-CB29-4133-8A55-D7DF955C7C71Q34877652-169FB55B-A1FE-4300-BEED-3E1E75BFB761Q34931247-408A805F-469D-47BA-A504-54D0598EBA4FQ34997089-08AE9145-1266-46BC-9177-F3BC44832E24Q35029623-98834072-90BA-427D-A6BA-7AA762AF8849Q35051199-592538CC-120F-4755-A78D-07609B785E89Q35072019-81FCFEED-D755-470C-89E6-6DE85F18029AQ35137659-0E4B8EC4-AD27-431F-81F0-C9B5D5B8B74AQ35184658-313B19D4-6ED5-4D6F-8C32-343765105775Q35302588-AF2829E4-BE44-4948-93FF-3101A1E1335AQ35343412-9CEA3784-287E-48B2-B163-836940EA0FC0Q35564087-1ED70250-2EE5-4D7E-8F4E-B8CBD6940C76Q35581892-E704EEFE-F96C-4296-BA71-E05CA0E18B89Q35582303-08BD6F0E-99AF-4629-94D8-E6F263594736
P2860
Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Association of small low-densi ...... tery disease in men and women.
@en
Association of small low-densi ...... tery disease in men and women.
@nl
type
label
Association of small low-densi ...... tery disease in men and women.
@en
Association of small low-densi ...... tery disease in men and women.
@nl
prefLabel
Association of small low-densi ...... tery disease in men and women.
@en
Association of small low-densi ...... tery disease in men and women.
@nl
P2093
P1476
Association of small low-densi ...... tery disease in men and women.
@en
P2093
C D Gardner
R M Krauss
S P Fortmann
P304
P356
10.1001/JAMA.1996.03540110029028
P407
P577
1996-09-01T00:00:00Z